|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
High on-treatment residual platelet reactivity is associated with an increased risk of adverse events after coronary stenting. Recent data suggest that cigarette smoking might enhance clopidogrel-mediated platelet inhibition. We therefore sought to investigate the influence of cigarette smoking on clopidogrel- and aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1879-2472
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
124
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
588-91
|
|
pubmed:meshHeading |
pubmed-meshheading:19631365-Aged,
pubmed-meshheading:19631365-Aspirin,
pubmed-meshheading:19631365-Blood Platelets,
pubmed-meshheading:19631365-Female,
pubmed-meshheading:19631365-Humans,
pubmed-meshheading:19631365-Male,
pubmed-meshheading:19631365-Middle Aged,
pubmed-meshheading:19631365-Platelet Aggregation,
pubmed-meshheading:19631365-Platelet Aggregation Inhibitors,
pubmed-meshheading:19631365-Retrospective Studies,
pubmed-meshheading:19631365-Smoking,
pubmed-meshheading:19631365-Ticlopidine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy.
|
|
pubmed:affiliation |
Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
